Chemed Price to Free Cash Flow Ratio 2012-2026 | CHE
Historical price to free cash flow ratio values for Chemed (CHE) since 2012.
| Chemed Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-09-16 | 509.91 | 21.44 | |
| 2026-06-30 | 465.13 | $23.78 | 19.56 |
| 2026-03-31 | 376.73 | $26.70 | 14.11 |
| 2025-12-31 | 426.18 | $22.82 | 18.67 |
| 2025-09-30 | 445.36 | $24.73 | 18.01 |
| 2025-06-30 | 483.68 | $24.86 | 19.45 |
| 2025-03-31 | 610.68 | $21.05 | 29.01 |
| 2024-12-31 | 525.32 | $24.45 | 21.49 |
| 2024-09-30 | 595.36 | $20.81 | 28.61 |
| 2024-06-30 | 537.05 | $16.83 | 31.91 |
| 2024-03-31 | 634.91 | $19.87 | 31.95 |
| 2023-12-31 | 577.97 | $18.03 | 32.05 |
| 2023-09-30 | 513.32 | $17.06 | 30.09 |
| 2023-06-30 | 534.60 | $18.52 | 28.86 |
| 2023-03-31 | 530.36 | $13.91 | 38.12 |
| 2022-12-31 | 503.04 | $16.88 | 29.80 |
| 2022-09-30 | 429.91 | $14.56 | 29.53 |
| 2022-06-30 | 461.87 | $18.45 | 25.04 |
| 2022-03-31 | 498.08 | $16.13 | 30.87 |
| 2021-12-31 | 519.78 | $15.74 | 33.03 |
| 2021-09-30 | 456.65 | $17.04 | 26.80 |
| 2021-06-30 | 465.49 | $17.50 | 26.60 |
| 2021-03-31 | 450.78 | $27.61 | 16.33 |
| 2020-12-31 | 521.74 | $26.35 | 19.80 |
| 2020-09-30 | 470.22 | $25.04 | 18.78 |
| 2020-06-30 | 441.26 | $25.12 | 17.57 |
| 2020-03-31 | 423.50 | $15.61 | 27.13 |
| 2019-12-31 | 429.11 | $15.02 | 28.57 |
| 2019-09-30 | 407.60 | $14.33 | 28.45 |
| 2019-06-30 | 351.96 | $13.06 | 26.95 |
| 2019-03-31 | 311.91 | $14.44 | 21.59 |
| 2018-12-31 | 275.81 | $13.94 | 19.78 |
| 2018-09-30 | 310.86 | $9.00 | 34.56 |
| 2018-06-30 | 312.74 | $7.14 | 43.83 |
| 2018-03-31 | 264.94 | $5.42 | 48.89 |
| 2017-12-31 | 235.71 | $5.87 | 40.19 |
| 2017-09-30 | 195.73 | $8.18 | 23.93 |
| 2017-06-30 | 197.85 | $7.03 | 28.15 |
| 2017-03-31 | 176.49 | $9.50 | 18.58 |
| 2016-12-31 | 154.74 | $5.70 | 27.17 |
| 2016-09-30 | 135.83 | $8.51 | 15.96 |
| 2016-06-30 | 131.01 | $7.57 | 17.30 |
| 2016-03-31 | 129.93 | $6.84 | 18.98 |
| 2015-12-31 | 143.43 | $7.31 | 19.62 |
| 2015-09-30 | 127.59 | $7.40 | 17.23 |
| 2015-06-30 | 125.13 | $5.22 | 23.97 |
| 2015-03-31 | 113.76 | $5.05 | 22.53 |
| 2014-12-31 | 100.48 | $3.74 | 26.87 |
| 2014-09-30 | 97.65 | $1.32 | 74.18 |
| 2014-06-30 | 88.75 | $4.15 | 21.37 |
| 2014-03-31 | 84.52 | $5.30 | 15.94 |
| 2013-12-31 | 72.22 | $6.54 | 11.05 |
| 2013-09-30 | 67.22 | $8.69 | 7.74 |
| 2013-06-30 | 67.90 | $6.94 | 9.78 |
| 2013-03-31 | 74.78 | $5.22 | 14.33 |
| 2012-12-31 | 63.98 | $4.99 | 12.82 |
| 2012-09-30 | 64.45 | $5.52 | 11.68 |
| 2012-06-30 | 56.06 | $7.11 | 7.89 |
| 2012-03-31 | 57.97 | $4.86 | 11.92 |
| 2011-12-31 | 47.24 | $6.91 | 6.84 |
| 2011-09-30 | 50.56 | $4.94 | 10.23 |
| 2011-06-30 | 60.10 | $3.93 | 15.29 |
| 2011-03-31 | 60.97 | $4.49 | 13.59 |
| 2010-12-31 | 58.01 | $2.62 | 22.13 |
| 2010-09-30 | 51.91 | $4.85 | 10.71 |
| 2010-06-30 | 49.66 | $4.88 | 10.18 |
| 2010-03-31 | 49.32 | $5.21 | 9.47 |
| 2009-12-31 | 43.41 | $6.13 | 7.08 |
| 2009-09-30 | 39.61 | $3.31 | 11.97 |
| 2009-06-30 | 35.53 | $3.91 | 9.09 |
| 2009-03-31 | 34.96 | $3.25 | 10.77 |
| 2008-12-31 | 35.69 | $3.70 | 9.66 |
| 2008-09-30 | 36.80 | $3.40 | 10.81 |
| 2008-06-30 | 32.76 | $3.66 | 8.96 |
| 2008-03-31 | 37.70 | $3.28 | 11.49 |
| 2007-12-31 | 49.87 | $3.03 | 16.44 |
| 2007-09-30 | 55.41 | $4.93 | 11.23 |
| 2007-06-30 | 59.03 | $3.12 | 18.93 |
| 2007-03-31 | 43.56 | $3.02 | 14.42 |
| 2006-12-31 | 32.86 | $2.89 | 11.39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $6.620B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |